The future of immune checkpoint cancer therapy after PD-1 and CTLA-4 von Hahn, Andrew W, Gill, David M, Pal, Sumanta K, Agarwal, Neeraj

Volltext

Radium‐223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration‐Refractory Prostate Cancer: Final Safety and Efficacy Results von Maughan, Benjamin L., Kessel, Adam, McFarland, Taylor Ryan, Sayegh, Nicolas, Nussenzveig, Roberto, Hahn, Andrew W., Hoffman, John M., Morton, Kathyrn, Sirohi, Deepika, Kohli, Manish, Swami, Umang, Boucher, Kenneth, Haaland, Benjamin, Agarwal, Neeraj

Volltext

Overview of Current and Future First-Line Systemic Therapy for Metastatic Clear Cell Renal Cell Carcinoma von Gill, David M., Hahn, Andrew W., Hale, Peter, Maughan, Benjamin L.

Volltext

The Influence of Obesity on Outcomes with Immune Checkpoint Blockade: Clinical Evidence and Potential Biological Mechanisms von Hahn, Andrew W, Venkatesh, Neha, Msaouel, Pavlos, McQuade, Jennifer L

Volltext

First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis von Hahn, Andrew W., Klaassen, Zachary, Agarwal, Neeraj, Haaland, Benjamin, Esther, John, Ye, Xiang Y., Wang, Xuechen, Pal, Sumanta K., Wallis, Christopher J.D.

Volltext

Missing the trees for the forest: most subgroup analyses using forest plots at the ASCO annual meeting are inconclusive von Hahn, Andrew W., Dizman, Nazli, Msaouel, Pavlos

Volltext

Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): pot... von Hahn, Andrew W, Gill, David M, Maughan, Benjamin, Agarwal, Archana, Arjyal, Lubina, Gupta, Sumati, Streeter, Jessica, Bailey, Erin, Pal, Sumanta K, Agarwal, Neeraj

Volltext

The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma von Hahn, Andrew W., Lebenthal, Justin, Genovese, Giannicola, Sircar, Kanishka, Tannir, Nizar M., Msaouel, Pavlos

Volltext

Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes von Alhalabi, Omar, Hahn, Andrew W, Msaouel, Pavlos, Andreev-Drakhlin, Alexander Y, Meric-Bernstam, Funda, Naing, Aung, Piha-Paul, Sarina, Filip, Janku, Pant, Shubham, Yap, Timothy A, Hong, David S, Fu, Siqing, Karp, Daniel, Campbell, Erick, Le, Hung, Campbell, Matthew T, Shah, Amishi Y, Tannir, Nizar M, Siefker-Radtke, Arlene O, Gao, Jianjun, Roszik, Jason, Subbiah, Vivek

Volltext

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma von Stenehjem, David D, Hahn, Andrew W, Gill, David M, Albertson, Daniel, Gowrishankar, Banumathy, Merriman, Joseph, Agarwal, Archana M, Thodima, Venkata, Harrington, Erik B, Au, Trang H, Maughan, Benjamin L, Houldsworth, Jane, Pal, Sumanta K, Agarwal, Neeraj

Volltext

Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience von Hahn, Andrew W., Thoman, Whittney, Koutroumpakis, Efstratios, Abdulla, Amer, Subudhi, Sumit K., Aparicio, Ana, Basen-Enngquist, Karen, Logothetis, Christopher J., Gilchrist, Susan C.

Volltext

Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome von Logothetis, Christopher J, Hahn, Andrew W

Volltext

The rapidly evolving treatment landscape of advanced prostate, bladder, and renal cell carcinomas von Hahn, Andrew W., Agarwal, Neeraj

Volltext

Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment von Hahn, Andrew W, Higano, Celestia S, Taplin, Mary-Ellen, Ryan, Charles J, Agarwal, Neeraj

Volltext

Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillance von Gregg, Justin R, Newcomb, Lisa, Wu, Ranran, Dennison, Jennifer, Davis, John W, Pettaway, Curtis, Pisters, Louis, Ward, John F, Chapin, Brian F, Chéry, Lisly, Urkmez, Ahmet, Fang, Andrew M, Higgason, Noel, Troncoso, Patricia, Daniel, Carrie R, Logothetis, Christopher, Thompson, Timothy C, Hahn, Andrew W, Liu, Menghan, Zheng, Yingye, Lin, Dan W, Hanash, Samir, Irajizad, Ehsan, Fahrmann, Johannes

Volltext

Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo’s Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dog... von Logothetis, Christopher J., Hahn, Andrew W.

Volltext

Obesity and renal cell carcinoma: Biological mechanisms and perspectives von Venkatesh, Neha, Martini, Alberto, McQuade, Jennifer L., Msaouel, Pavlos, Hahn, Andrew W.

Volltext

Immunotherapy of advanced renal cell carcinoma: Current and future therapies von Gill, David, Hahn, Andrew W., Sonpavde, Guru, Agarwal, Neeraj

Volltext

An Evolving Role for AXL in Metastatic Renal Cell Carcinoma von Hahn, Andrew W, George, Daniel J, Agarwal, Neeraj

Volltext

Current Treatment Landscape of Advanced Papillary Renal Cancer von Shuch, Brian, Hahn, Andrew W, Agarwal, Neeraj

Volltext